Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
Phase of Trial: Phase II
Latest Information Update: 20 Feb 2019
Price : $35 *
At a glance
- Drugs Finasteride (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Elorac
- 17 May 2018 According to the Elorac media release, data from this study will be presented at the Society For Investigative Dermatology (SID) Annual Meeting 2018.
- 19 Jul 2017 Status changed from recruiting to completed.
- 06 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.